Increasing liquid biopsy sensitivity to the next level: usability of minimal residual disease detection by longitudinal genomic fusion tracing using specific digital droplet PCR (ddPCR) in non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibition (ICI) plus /- chemotherapy

被引：0

作者：

Griesinger, Frank ^{[1
]}

Roeper, Julia ^{[1
]}

Overbeck, Tobias ^{[2
]}

Willborn, Kay ^{[3
]}

Stroebel, Philipp ^{[2
]}

Asendorf, Thomas ^{[2
]}

Halfen, Jessica ^{[2
]}

Golpon, Heiko ^{[4
]}

Schuetz, Ekke ^{[5
]}

Borkar, Srushti ^{[1
]}

Markus, Fenja ^{[6
]}

Voessing, C. ^{[6
]}

Weist, P. ^{[6
]}

Heukamp, Lukas ^{[6
]}

机构：

[1] Carl von Ossietzky Univ Oldenburg, Pius Hosp, Oldenburg, Germany

[2] UMG, Gottingen, Germany

[3] Pius Hosp, Oldenburg, Germany

[4] MHH, Hannover, Germany

[5] GmbH Oncocyte Co, Gottingen, Germany

[6] Lungenkrebsmed Oldenburg GbR, Oldenburg, Germany

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

700

引用

页码：133 / 133

页数：1